OriliTM

Elagolix
Endometriosis Management (Hormone Preparation)

Indication:
OriliTM 200 tablet is indicated for the management of moderate to severe pain associated with endometriosis.

Dosage & Administration:
Pregnancy should be excluded before starting treatment with elagolix and start elagolix within 7 days from the onset of menses. Initial treatment with elagolix 200 mg twice daily up to 6 months (with coexisting dyspareunia). Treatment with elagolix 200 mg should not exist more than 6 months as it may decrease bone mineral density (BMD). In case of moderate to severe hepatic impairment elagolix 200 mg is not recommended.

Preparation:
Each box contains 12 tablets in alu-alu blister strip.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides